Neurotherapeutics Pharmacology
Cell-based intravitreal enzyme replacement therapy slows deterioration of retinal structure and function in a mouse model of neuronal ceroid lipofuscinosis type 1 (CLN1)
The publisher did not provide an abstract — full text is available via the link below.